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Abstract 
Background 
For almost 30 years, transanal endoscopic microsurgery (TEM) has been the mainstay treatment for 
large rectal lesions. With the advent of endoscopic submucosal dissection (ESD), flexible 
endoscopy has aimed at en bloc R0 resection of superficial lesions of the digestive tract. This 
systematic review and meta-analysis compared the safety and effectiveness of ESD and full-
thickness rectal wall excision by TEM in the treatment of large nonpedunculated rectal lesions 
preoperatively assessed as noninvasive. 
Methods 
A systematic review of the literature published between 1984 and 2010 was conducted (Registration 
no. CRD42012001882). Data were integrated with those from the original databases requested from 
the study authors when needed. Pooled estimates of the proportions of patients with en bloc R0 
resection, complications, recurrence, and need for further treatment in the ESD and TEM series 
were compared using random-effects single-arm meta-analysis. 
Results 
This review included 11 ESD and 10 TEM series (2,077 patients). The en bloc resection rate was 
87.8 % (95 % confidence interval [CI] 84.3–90.6) for the ESD patients versus 98.7 % (95 % CI 
97.4–99.3 %) for the TEM patients (P < 0.001). The R0 resection rate was 74.6 % (95 % CI 70.4–
78.4 %) for the ESD patients versus 88.5 % (95 % CI 85.9–90.6 %) for the TEM patients 
(P < 0.001). The postoperative complications rate was 8.0 % (95 %, CI 5.4–11.8 %) for the ESD 
patients versus 8.4 % (95 % CI 5.2–13.4 %) for the TEM patients (P = 0.874). The recurrence rate 
was 2.6 % (95 % CI 1.3–5.2 %) for the ESD patients versus 5.2 % (95 % CI 4.0–6.9 %) for the 
TEM patients (P < 0.001). Nevertheless, the rate for the overall need of further abdominal 
treatment, defined as any type of surgery performed through an abdominal access, including both 
complications and pathology indications, was 8.4 % (95 % CI 4.9–13.9 %) for the ESD patients 
versus 1.8 % (95 % CI 0.8–3.7 %) for the TEM patients (P < 0.001). 
Conclusions 
The ESD procedure appears to be a safe technique, but TEM achieves a higher R0 resection rate 
when performed in full-thickness fashion, significantly reducing the need for further abdominal 
treatment. 
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For nearly 30 years, transanal endoscopic microsurgery (TEM) has been the optimal mainstay 
treatment for large rectal lesions. Initially conceived for treating benign lesions, its indications were 
extended to early rectal cancer treatment when Hermanek and Gall [1] assessed criteria to determine 
lesions at “low risk” for recurrence. One increasingly recognized advantage of the technique versus 
standard transanal surgery is the high rate of en bloc resection with disease-free margins, which is 
strictly related to the risk of recurrence [2]. 
With the advent of endoscopic submucosal dissection (ESD) about 10 years ago, flexible endoscopy 
permitted a surgical-like technique for en bloc resection of superficial lesions of the digestive tract. 
First indicated for the upper gastrointestinal tract [3], ESD then was applied to the lower 
gastrointestinal tract with promising results [4]. Although ESD represents an alternative to 
endoscopic mucosal resection (EMR) of the colon, its application to the rectum can be compared 
with TEM, both aiming to achieve en bloc R0 excision. 
This study aimed to evaluate in a systematic review and meta-analysis whether ESD has clinically 
relevant short-term advantages in terms of safety and effectiveness compared with TEM in the 
treatment of large nonpedunculated rectal lesions preoperatively assessed as noninvasive. 
Methods 
The methods for the analysis and generation of inclusion criteria were based on the Cochrane 
Collaboration guidelines [5] and the PRISMA recommendations [6]. According to population, 
interventions, comparators, outcome measures, and setting (PICOS) criteria, patients were included 
if they had large nonpedunculated rectal lesions preoperatively assessed as noninvasive for which 
either TEM or ESD was indicated. The study methods were documented in a protocol registered 
and accessible at http://www.crd.york.ac.uk/prospero/ (Registration no. CRD42012001882). 
Criteria for identifying studies and eligibility 
The study aimed to include randomized or quasi-randomized studies that directly compared TEM 
and ESD. Because we knew and verified that similar studies were not available, we included 
prospective series that examined one of the two treatments provided they had the same inclusion 
and exclusion criteria. To be eligible, studies had to include reports on patients with a large (>2 cm) 
nonpedunculated rectal lesion preoperatively assessed as noninvasive by digital examination and/or 
endoscopic ultrasound (EUS) (confined to the mucosal layer) or lesions treated endoscopically by 
the ability to be lifted when the submucosal layer was injected below the lesion. 
The exclusion criteria ruled out preoperative biopsies positive for invasive malignancy when 
available, TEM performed in a non-full-thickness fashion, and the impossibility to hive-off data 
from mixed series. Also excluded were studies reporting data on colon and rectal lesions that could 
not be broken up. 
The criteria required that TEM had been performed in full-thickness fashion according to the 
technique described by Buess et al. [7]. When the technique was not specified, the authors were 
contacted for confirmation. Articles were included if a submucosal dissection was performed by 
TEM only for those lesions at risk for peritoneal opening. The criteria required that ESD had been 
performed after submucosal injection and lifting by any of the techniques described in the literature, 
including the different knives available. 
Because most of the ESD series merged data on colonic and rectal lesions in a way that the two 
types could not be distinguished, the authors were contacted to provide a database of their published 
series restricted to rectal lesions only. Rectal lesions were defined as any lesion with an upper 
margin located within 18 cm of the anal verge, which was assessed by means of rigid rectoscopy in 
the TEM series and by flexible endoscopy in the ESD series. 
End points 
The primary end point of this review was effectiveness of resection (i.e., en bloc resection rate, 
defined as the rate of lesions excised in a single specimen, and R0 resection rate, defined as the rate 
of lesions excised with margins free of disease) as assessed by the pathologist. The secondary end 
points were size of the lesions excised, time for completion of the procedure, safety (i.e., 
postprocedural complications such as bleeding and perforation and the need for abdominal surgery 
to manage complications), recurrence rate as assessed by a minimum of 6 months follow-up 
evaluation, the need for abdominal surgery for oncologic reasons, and finally the overall need for 
abdominal surgery. Abdominal surgery was defined as any type of surgery performed through an 
abdominal access. 
Search strategy 
Searches of the published literature were conducted for the period between January 1984 and 
December 2010. Only articles published in English or German were included. Studies were 
identified by electronic searches of Pubmed and EMBASE. 
The following strategy was used to search both PubMed and EMBASE at a single time during 
January 2011: endoscopic AND submucosal AND resection* OR (endoscopic AND submucosal 
AND dissection*) OR (endoscopic AND submucosal AND excision*) OR (endoscopic AND 
mucosal AND resection*) OR (endoscopic AND resection*) OR (endoscopic AND excision*) OR 
(endoscopic AND mucosal AND excision*) OR (endoscopic AND treatment*) OR (endoscopic 
AND therapy*) OR (rectoscopic AND mucosal AND resection*) OR (rectoscopic AND resection*) 
OR (rectoscopic AND excision*) OR (rectoscopic AND mucosal AND excision*) OR (rectoscopic 
AND treatment*) OR (rectoscopic AND therapy*) OR (colonoscopic AND mucosal AND 
excision*) OR (colonoscopic AND resection*) OR (colonoscopic AND excision*) OR 
(colonoscopic AND treatment*) OR (colonoscopic AND therapy*) AND (colorectal AND 
‘neoplasms’/exp OR (colorectal AND tumor*) OR (colorectal AND tumour*) OR (colorectal AND 
neoplasm*) OR (‘rectal’/exp AND neoplasm*) OR (‘adenoma’/exp AND (‘rectum’/exp OR 
‘rectal’/exp OR colorectal))) OR (tem OR (transanal AND endoscopic AND ‘microsurgery’/exp) 
AND ‘surgery’/exp OR transanal OR peranal AND (colorectal AND ‘neoplasms’/exp OR 
(colorectal AND tumor*) OR (colorectal AND tumour*) OR (colorectal AND neoplasm*) OR 
(‘rectal’/exp AND neoplasm*) OR (‘adenoma’/exp AND (‘rectum’/exp OR ‘rectal’/exp OR 
colorectal)))) AND ‘rectal’/exp AND ‘neoplasm’/exp AND (‘endoscopy’/exp OR endoscopic OR 
‘microsurgery’/exp OR transanal OR mucosal OR ‘resection’/exp) OR (endoscopic AND mucosal 
AND ‘resection’/exp) OR (endoscopic AND submucosal AND ‘dissection’/exp) AND [1984-
2010]/py.  
Study selection 
Titles were screened by two authors (A.A. and M.V.) to exclude nonrelated publications. Studies 
were excluded if the interventions, as reported in the abstracts, clearly differed from ESD or TEM 
or did not focus on the colorectal area. 
The full text of the remaining articles was read to determine whether they were eligible for 
inclusion in the review. Studies were excluded in which preoperatively assessed rectal cancers were 
treated. When the same data of a single research group were reported in multiple publications, only 
the study reporting on the largest cohort was included. 
Data extraction was independently performed by the two reviewers using predefined data extraction 
forms. A third investigator (M.M.) arbitrated in the event that agreement was not reached. 
From each report, the reviewers independently collected the following data when available: year of 
publication, prospective or retrospective study design, enrollment period, number of patients 
included, mean age, gender distribution, lesion location (colon/rectum), Kudo pit-pattern 
classification [8], EUS, type of device used, mean operating time, mean tumor size, complication 
rate, rate of surgery due to complications, histology (adenoma, carcinoma in situ, invasive cancer, 
carcinoid), rate of histologically verified en bloc resection, rate of histologically verified complete 
resection (R0), rate of surgery for oncologic reasons, follow-up evaluation, histologically 
demonstrated recurrence, and need of further treatment for disease recurrence. 
Quality assessment 
All the studies fulfilling the selection criteria for this review were assessed to determine 
methodologic quality and risk of bias. The following quality items were scored: study design, 
sequence generation, cohort size, lesion type before intervention, lesion size, incidence of invasive 
carcinomas at final histology, length of the follow-up period, and objective definition of outcome 
parameters (complications and recurrence). 
Table 1 reports the individual scores of quality assessment items per study. Because the data on 
colonic and rectal lesions from most of the ESD series were merged in such a way that they could 
not be distinguished, the authors were asked to provide a database of their published series 
restricted to rectal lesions only. 
 Table 1  
Individual scores of quality assessment items per study  
Study characteristics Tumor 
characteristics Outcome assessment: safety 
Outcome assessment: 
effectiveness 
Author Year Intervention 
n  Study design Consecutive 
series 
Mean (±SD) 
size of lesions 
(mm) 
Complications 
reported 
Objective 
definition of 
complication 
Recurrences 
reported 
Objective 
definition 
of 
recurrence 
Fujishiro et 
al. [11] 2006 ESD 35 Unclear Yes 26.2 ± 14.0 Yes No Yes No 
Onozato et 
al. [12] 2007 ESD 30 Retrospective Yes 32.8 ± NA Yes No Yes No 
Ohya et al. 
[13] 2009 ESD 45 Unclear Yes 35.0 ± NA Yes No No No 
Iizuka et al. 
[14] 2009 ESD 26 Retrospective Unclear 36.0 ± 20.0 Yes No No No 
Uraoka et al. 
[15] 2010 ESD 37 Retrospective Yes NA Yes No No No 
Ishii et al. 
[16] 2010 ESD 9 Retrospective Unclear 34.0 ± 16.0 Yes No Yes Yes 
Takeuchi et 
al. [17] 2010 ESD 14 Prospective Unclear 28.7 ± NA Yes No No No 
Yoshida et 
al. [18] 2010 ESD 110 Unclear Unclear 29.1 ± NA Yes No No No 
Saito et al. 
[19] 2010 ESD 158 Prospective Yes 35.0 ± 18.0 Yes No No No 
Fusaroli et al. 
[20] 2009 ESD 8 Unclear Unclear 41.9 ± NA Yes No No No 
Niimi et al. 
[21] 2010 ESD 64 Retrospective Yes 28.9 ± NA Yes No No No 
Said and 
Stippel [22] 1996 TEM 260 Retrospective No NA Yes No Yes Yes 
Cocilovo et 
al. [23] 2003 TEM 56 Prospective Unclear 49.0 ± 22.8 Yes No Yes No 
Langer et al. 
[24] 2003 TEM 79 Retrospective No 33.0 ± 15.0 Yes No Yes No 
Neary et al. 
[25] 2003 TEM 21 Prospective Yes 39.0 ± 26.0 Yes No Yes No 
Schafer et al. 
[26] 2006 TEM 33 Retrospective Unclear 91.2 ± 22.8 Yes No Yes No 
Ganai et al. 
[27] 2006 TEM 134 Retrospective Unclear 31.0 ± 14.0 Yes No Yes Yes 
Doornebosch 
et al. [28] 2008 TEM 47 Prospective Yes 44.7 ± 13.3 Yes Unclear Yes No 
Guerrieri et 
al. [29] 2010 TEM 402 Retrospective Unclear NA Yes No Yes No 
De Graaf et 
al. [30] 2011 TEM 216 Prospective Unclear 30.0 ± NA Yes No Yes Yes 
Morino et al. 
[31] 2011 TEM 293 Prospective Unclear 50.0 ± NA Yes No Yes No 
ESD endoscopic submucosal dissection, NA not available, TEM transanal endoscopic microsurgery 
Statistical analysis 
All analyses were performed according to the original treatment allocation (intention-to-treat 
analysis). Fixed- and random-effects meta-analyses of studies reporting single proportions were 
used to calculate an overall proportion. Because all the studies reported the results of only one 
technique in a series of patients, the logit transformed proportion of patients with recurrence or 
complication was used as the outcome parameter in the meta-analysis. We added 0.5 to all the cell 
frequencies of studies with a zero cell count. 
Particularly, the random-effects model incorporates any remaining variability beyond chance that 
exists among studies, taking into account differences in sample size whereby proportions have been 
measured in each trial. This within-study variation was accounted for by using the exact binomial 
distribution. Individual and pooled estimates of these proportions together with 95 % confidence 
intervals (95 % CI) on recurrence and complication rates then were presented in the forest plots. 
Operating time and tumor size were compared using their reported means and standard deviations 
(SDs). When means and/or SDs were not reported, they were estimated from the reported medians 
and ranges using the Hozo et al. [9] approach. 
Potential sources of heterogeneity were explored in three different sensitivity analyses: fixed versus 
random-effects models (with the second model incorporating heterogeneity), cumulative meta-
analysis (sequential inclusion of studies by date of publication), and influence meta-analysis 
(calculation of pooled estimates with omission of one study at a time). 
All analyses were performed using R 2.15.0 and Meta-analyst 3.13 (for continuous outcomes) (R 
Foundation for Statistical Computing, Vienna, Austria) [10]. 
Results 
The search retrieved 9,315 studies. The selection procedure is illustrated in Fig. 1. Of the 9,315 
studies, 57 were excluded because it was unclear whether full-thickness TEM procedures were 
performed and whether an ESD procedure was performed to treat colonic or rectal lesions. We were 
unable to clarify these doubts because we received no reply to our request from the respective study 
authors. In all, 21 studies met the inclusion criteria for a total of 2,077 patients: 11 ESD series [11–
21] totaling 536 patients, and 10 TEM series [2, 22–30], totaling 1,541 patients. 
 Fig. 1  
Flow chart diagram of the systematic search and study selection strategy 
The mean polyp size was 35 mm (95 % CI 31–39 mm) in the ESD series versus 40 mm (95 % CI 
29–51 mm) in the TEM series (P = 0.393). The operating time was 96 min (95 % CI 84–107 min) in 
the ESD series versus 67 min (95 % CI 53–82 min) in the TEM series (P = 0.003). 
En bloc and RO resection 
The en bloc resection rate was available for 9 ESD and 9 TEM series. The pooled estimate of the 
proportion of patients was 87.8 % (95 % CI 84.3–90.6 %) in the ESD series and 98.7 % (95 % CI 
97.4–99.3 %) in the TEM series (P < 0.001, Fig. 2). Heterogeneity was greater in the ESD series (I 
2
 = 60.1 %) than in the TEM series (I 2 = 46.4 %). 
 Fig. 2  
En bloc resection rates for ESD and TEM, showing a statistically significant advantage of TEM 
(P < 0.001) 
The cumulative meta-analysis of all 18 studies showed a progressive increase from 81.4 to 95.1 % 
in the proportion of patients undergoing en bloc resection. The same proportion was quite constant 
(94.3–95.8 %), with no study strongly affecting the results in the influential, leave-one-out meta-
analysis. 
The R0 resection rate was available for 9 ESD and 8 TEM series. The pooled estimate of the 
proportion of patients was 74.6 % (95 % CI 70.4–78.4 %) in the ESD series and 88.5 % (95 % CI 
85.9–90.6 %) in the TEM series (P < 0.001, Fig. 3). Heterogeneity was lower in the ESD series (I 
2
 = 52.9 %) than in the TEM series (I 2 = 69.1 %). The cumulative meta-analysis of all 17 studies 
showed a progressive increase from 62.9 to 82.7 % in the proportion of patients undergoing R0 
resection. Again, the same proportion was quite constant (81.4–83.7 %) in the influential meta-
analysis. 
 Fig. 3  
R0 resection rates for ESD and TEM, showing a statistically significant advantage of TEM 
(P < 0.001) 
Perioperative complications 
Data regarding perioperative complications were retrieved for all 11 ESD series and 8 of the TEM 
series. Altogether, 1,887 patients (536 ESD and 1,351 TEM patients) were included in the analysis 
of complications. The complications after ESD were rectal bleeding (n = 19) and perforation 
(n = 20). The complications after TEM were suture leakage (n = 43), rectal bleeding (n = 30), 
fistulas (n = 7), urinary infection or retention (n = 6), and others (n = 11). 
The proportion of patients with complications was 8.0 % (95 % CI 5.4–11.8 %) after ESD versus 
8.4 % (95 % CI 5.2–13.4 %) after TEM (P = 0.874, Fig. 4). Heterogeneity was low in the ESD 
series (I 2 = 25.0 %) but extreme by comparison in the TEM series (I 2 = 80.5 %). A cumulative 
meta-analysis of all 19 studies showed a progressive increase from 4.2 to 8.6 % in the proportion of 
patients with complications. This proportion ranged from 7.1 to 8.7 %, without any single-trial 
effect, in the influential meta-analysis. 
 Fig. 4  
Perioperative complication rates after ESD and TEM, showing substantial equivalence between the 
two groups (P = 0.874) 
The pooled proportion of patients with perioperative events requiring additional abdominal surgery 
for complication control was 1.3 % (95 % CI 0.5–3.3 %) in the ESD series and 1.6 % (95 % CI 1.0–
2.6 %) in the TEM series (P = 0.665, Fig. 5). Heterogeneity was absent in the ESD series (I 
2
 = 0.0 %) and low in the TEM series (I 2 = 14.4 %). A cumulative meta-analysis showed that 1.1–
2.1 % of the patients required additional abdominal surgery. The influential meta-analysis showed a 
range of 1.3–1.7 %. 
 Fig. 5  
Need for additional abdominal surgery for control of complications after ESD and TEM, showing a 
substantial equivalence between the two groups (P = 0.665) 
Histology 
Only nine ESD and eight TEM series provided histology data. In all, 1,929 patients (488 ESD and 
1,441 TEM patients) were included in the analyses of histology. Final pathology demonstrated an 
adenoma in 156 ESD patients (31.9 %) and 1,278 TEM patients (89.1 %), pTis or pT1sm1 cancers 
in 279 ESD patients (57.1 %) and 79 TEM patients (5.5 %), and invasive adenocarcinoma (pT1sm2 
or more) in 45 ESD patients (9.2 %) and 73 TEM patients (5.1 %). Eight patients in the ESD group 
and four in the TEM group had another diagnosis. 
The pooled estimate of the proportion of patients with invasive adenocarcinoma was 9.5 % (95 % 
CI 5.7–15.5 %) in the ESD series and 3.9 % (95 % CI 1.5–9.7 %) in the TEM series (P = 0.095). 
Heterogeneity was moderate in the ESD series (I 2 = 50.7 %) but extreme in the TEM series (I 
2
 = 88.2 %). The cumulative meta-analysis showed that 6.7–11.5 % of the patients required 
additional abdominal surgery. The influential meta-analysis showed a range of 5.0–7.8 %. 
 
Recurrences and oncologic criteria 
Only seven ESD series and nine TEM series provided recurrence data. All the ESD series reported a 
follow-up period of 6–12 months, whereas the TEM series reported an average follow-up period of 
58.9 months (range, 1–204 months). In all, 1,811 patients (404 ESD and 1407 TEM patients) were 
included in the analyses of recurrences. The pooled estimate of the proportion of patients with 
adenoma recurrence was 2.6 % (95 % CI 1.3–5.2 %) in the ESD series and 5.2 % (95 % CI 4.0–
6.9 %) in the TEM series (P = 0.068). 
Heterogeneity was absent in the ESD series (I 2 = 0.0 %) and low in the TEM series (I 2 = 21.5 %). 
The pooled proportion of patients with perioperative events requiring additional abdominal surgery 
for oncologic indications or recurrence was 8.4 % (95 % CI 4.9–13.9 %) in the ESD series and 
2.9 % (95 % CI 1.5–5.4 %) in the TEM series (P = 0.011). Heterogeneity was moderate in the ESD 
series (I 2 = 40.2 %) and greater in the TEM series (I 2 = 63.3 %). 
Need for abdominal surgery 
Data regarding the overall need for abdominal surgery, defined as any type of surgery performed 
through an abdominal access, were retrieved for eight ESD and nine TEM series. This included 
treatment of complications, recurrence, or major surgery for oncologic curative resection, as 
reported earlier. In all, 1,862 patients (455 ESD and 1407 TEM patients) were included in the 
analysis. The pooled estimate of the proportion of patients requiring abdominal surgery was 8.4 % 
(95 % CI 4.9–13.9 %) in the ESD series and 1.8 % (95 % CI 0.8–3.7 %) in the TEM series 
(P < 0.001, Fig. 6). Heterogeneity was moderate in both the ESD (I 2 = 40.2 %) and TEM (I 
2
 = 48.1 %) series. 
 Fig. 6  
Proportions of patients requiring abdominal surgery in the ESD and TEM series, showing a 
statistically significant lower incidence after TEM (P < 0.001) 
Discussion 
One of the most important risk factors for recurrence of rectal lesions is an R1 resection [2, 31, 32], 
which is obviously less probable when an en bloc resection is attempted. A recent systematic review 
by Barendse et al. [33] reported a recurrence rate of 11.2 % at 3 months after piecemeal EMR for 
colorectal lesions, which dropped to 1.5 % at 3 months after further endoscopic treatment. The 
authors claimed that this demonstrated the equivalence of EMR and TEM. However, the analysis 
contained a number of flaws. The two major flaws were that (1) all but one endoscopic series 
included only benign lesions, which suggested an evident selection of cases based on postoperative 
histology, and that (2) most of the TEM series included cases managed by a partial wall excision 
rather than a full-thickness technique, as suggested by most expert authors [29]. 
Due to the high rate of preoperatively misdiagnosed malignancies, piecemeal resection, as obtained 
by EMR, should not be performed when valid alternatives are available. Currently, surgeons 
performing endoscopic resection of a noninvasive rectal lesion should aim to use an ESD technique. 
Although rectal lesions currently are diagnosed earlier than in the past and can be treated with a 
variety of different techniques, we found no randomized or quasi-randomized study comparing ESD 
with TEM. Furthermore, although a meta-analysis of only randomized controlled trials would be 
ideal, case series data are the only evidence available to date. 
The major limitation in the meta-analysis of the aforementioned data was the potential confounding 
by a systematic difference in patient characteristics between the two groups. In fact, although 
patients eligible for ESD will necessarily be assessed as having a superficial lesion, TEM often is 
performed also for those with an invasive lesion and almost always as a full-thickness excision. For 
this reason, we defined strict inclusion criteria that required a rectal lesion larger than 2 cm in 
diameter preoperatively assessed as a superficial neoplasm. By defining strict inclusion criteria, we 
excluded all TEM series that included preoperatively assessed malignant lesions because they were 
most probably biased by an extension of the inclusion criteria. The size limit requiring that lesions 
be larger than 2 cm was set according to the Japanese Society for Cancer of the Colon and Rectum 
(JSCCR) guidelines [34], which aims to achieve en bloc resection with no fragmentation. 
With these restrictions in selection, heterogeneity of the results was kept within a reasonable frame, 
although some of the study samples included in this analysis were relatively small. We also 
performed additional analyses to adjust for these potential confounders, which indicated that their 
impact was null. By restricting the analysis to rectal lesions, we sought to limit any biases related to 
anatomic situations, which can influence the handling of lesions due to endoscope maneuverability 
restricted proximally to the rectum. As a consequence, the sensitivity analyses showed that no study 
had an influential effect on relative risk in the whole time frame. 
A previous study comparing ESD with transanal excision (TAE) showed an advantage of ESD with 
respect to higher achievement of R0 en bloc resections [35]. Nonetheless, it is known that TEM is 
superior to TAE for the same reason, resulting in a significantly higher recurrence-free survival 
[36]. 
The TEM procedure remains the gold standard surgical treatment for rectal local excision. The 
pooled results of the current systematic review indicate that ESD for nonpedunculated superficial 
lesions of the rectum larger than 2 cm in diameter appears to be less effective than TEM, with an en 
bloc resection achieved for 88 % of patients compared with 99 % for TEM. Even more 
significantly, an R0 resection was achieved for 74 % of patients using ESD compared with 89 % 
using TEM. This difference was statistically significant. The apparently lower risk of recurrence 
shown in the ESD group was in fact not statistically significant, and in any case probably was due 
to the shorter follow-up period reported for the ESD series. 
The ESD procedure is technically demanding with the currently available equipment and requires a 
significantly longer time to be completed. Yet the perioperative complication rate compared 
favorably with that of the TEM series, and the rate of abdominal surgery controlling complications 
was negligible. 
Postoperative histology assessment demonstrated a much higher incidence of adenocarcinoma in 
the ESD series, which was attributable to a different way of classifying intramucosal lesions [37]. 
The rates of unpredicted invasive cancers treated in the two groups were comparable, but this 
required further surgery for oncologic reasons about four times more often in the ESD group due to 
the higher incidence of R1 resections than in the TEM group. In fact, a positive vertical margin after 
endoscopic resection is considered to be an indication for intestinal resection with lymph node 
dissection [34]. 
The high rate of further surgery for oncologic reasons after ESD also may explain the reduced risk 
of recurrence in this group. Although this could not be assessed through the analysis of the selected 
papers, the reduced incidence of abdominal surgery after TEM might be due to the fact that patients 
with a cancer extended to the submucosal layer who received an R0 full-thickness resection often 
refused to undergo intestinal resection with lymph node dissection due to the limited risk of 
metastasis. 
An indisputable advantage of ESD for rectal lesions is that it does not entail the need for general 
anesthesia or a prolonged hospital stay, as usually is the case after full-thickness TEM resection, 
although this more often is a trend or based on a difference in the practice of surgeons and 
endoscopists. On the other hand, TEM supporters could argue that preoperative assessment of 
benign or noninvasive lesions still is suboptimal, so that even in this analysis, a consistent number 
of cases actually resulted in malignancy.  
The intraoperative finding of deep wall invasion misdiagnosed preoperatively can significantly 
influence oncologic outcome. Moreover, the risk for infiltration of the vertical margin is the only 
risk factor for recurrence and the reason why EMR should be avoided in such circumstances [34]. 
Of extreme interest would have been the influence on anal continence and rectal function, sexual 
and urinary dysfunction, and quality of life, but the lack of sufficient data on these issues precluded 
further analyses. 
Based on the evidence of the current review and analysis, we can conclude that TEM achieves a 
higher rate of en bloc and R0 excision. As a consequence, full-thickness rectal wall excision by 
TEM significantly reduces the need for further abdominal treatment. How these results will 
ultimately translate into common daily clinical practice remains unclear. No randomized head-to-
head comparisons between TEM and ESD have been performed to date. Our review clearly 
highlights the need for a large randomized study to obtain unbiased results on the effectiveness and 
safety of these two strategies for patients with large rectal lesions preoperatively assessed as 
adenomas or noninvasive neoplasms.  
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